Drug Research
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.4 | Q3 | 39.9% | 0.479 | Q3 | 59.4% |
| 2024 | 2.1 | Q3 | 37.4% | 0.415 | Q3 | 56.1% |
| 2023 | 1.7 | Q3 | 30.4% | 0.390 | Q3 | 56.9% |
| 2022 | 2.2 | 36.8% | 0.363 | Q3 | 56.4% | |
| 2021 | — | 24.0% | 0.326 | Q3 | 54.0% | |
| 2020 | — | — | 0.433 | Q3 | 61.9% | |
| 2019 | — | — | 0.355 | Q3 | 57.5% | |
| 2018 | — | — | 0.437 | Q3 | 61.4% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2194-9387
ISSN
2194-9379
country
DEcoverage
1972, 2013-2026